The FDA has accepted the sNDA for avatrombopag for the treatment of thrombocytopenia in pediatric patients aged 1 year and ...

Immune globulin (human) is under clinical development by Grifols and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Fostamatinib disodium is under clinical development by Rigel Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Rigel Pharmaceuticals has shown significant growth, particularly from the acquisition of pralsetinib. Read why RIGL stock is ...

In the phase 3 LUNA 3 trial, rilzabrutinib, compared with placebo, improved efficacy and QOL outcomes with an accompanying ...

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...

The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; Cipterbin, an anti-HER2 monoclonal antibody for the treatment of ...

Despite this setback, the company continues to progress with its phase 1-2 study of CID-103 for chronic Immune Thrombocytopenia (ITP), with patient recruitment expected to begin in the first quarter ...

Technical Guidelines for Clinical Trials of Intravenous Human Immunoglobulin for the Treatment of Primary Immune Thrombocytopenia 320 drugs removed from medical insurance (list attached) The same work ...

Lauren Harless, a registered nurse at Sovah Health-Danville was honored recently with The DAISY Award For Extraordinary ...